Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Iconovo AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr10.25 |
52 Week High | kr32.00 |
52 Week Low | kr7.46 |
Beta | 0.73 |
1 Month Change | 15.43% |
3 Month Change | 28.13% |
1 Year Change | -65.83% |
3 Year Change | -87.80% |
5 Year Change | -76.60% |
Change since IPO | -71.53% |
Recent News & Updates
Recent updates
We're A Little Worried About Iconovo's (STO:ICO) Cash Burn Rate
Jul 06Here's Why We're Watching Iconovo's (STO:ICO) Cash Burn Situation
Jul 29Companies Like Iconovo (STO:ICO) Are In A Position To Invest In Growth
Nov 10We're Not Worried About Iconovo's (STO:ICO) Cash Burn
Jul 31Is Now The Time To Look At Buying Iconovo AB (publ) (STO:ICO)?
Jul 12Iconovo AB (publ)'s (STO:ICO) Intrinsic Value Is Potentially 37% Above Its Share Price
Jun 13Companies Like Iconovo (STO:ICO) Can Afford To Invest In Growth
Apr 13When Will Iconovo AB (publ) (STO:ICO) Turn A Profit?
Mar 18Have Iconovo AB (publ) (STO:ICO) Insiders Been Selling Their Stock?
Feb 20A Look At Iconovo's (STO:ICO) Share Price Returns
Feb 07Have Insiders Been Buying Iconovo AB (publ) (STO:ICO) Shares?
Dec 21Shareholder Returns
ICO | SE Medical Equipment | SE Market | |
---|---|---|---|
7D | -6.0% | -0.9% | -0.8% |
1Y | -65.8% | -11.7% | 12.8% |
Return vs Industry: ICO underperformed the Swedish Medical Equipment industry which returned -11.7% over the past year.
Return vs Market: ICO underperformed the Swedish Market which returned 12.8% over the past year.
Price Volatility
ICO volatility | |
---|---|
ICO Average Weekly Movement | 8.1% |
Medical Equipment Industry Average Movement | 7.0% |
Market Average Movement | 5.9% |
10% most volatile stocks in SE Market | 12.9% |
10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: ICO's share price has been volatile over the past 3 months.
Volatility Over Time: ICO's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 29 | Johan Waborg | www.iconovo.se |
Iconovo AB (publ) develops and licenses inhalation medications in Sweden. The company offers ICOres, a flexible multi-dose dry powder inhaler; ICOcap, a capsule based dry powder inhaler; ICOone, a single-dose disposable dry powder inhaler; and ICOpre, a pre-metered dry powder inhaler; and ICOone Nasal single-dose dry powder inhaler for nasal use. It serves generic companies.
Iconovo AB (publ) Fundamentals Summary
ICO fundamental statistics | |
---|---|
Market cap | kr163.16m |
Earnings (TTM) | -kr42.40m |
Revenue (TTM) | kr28.08m |
5.8x
P/S Ratio-3.8x
P/E RatioIs ICO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ICO income statement (TTM) | |
---|---|
Revenue | kr28.08m |
Cost of Revenue | kr8.24m |
Gross Profit | kr19.84m |
Other Expenses | kr62.24m |
Earnings | -kr42.40m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 12, 2024
Earnings per share (EPS) | -2.66 |
Gross Margin | 70.64% |
Net Profit Margin | -151.00% |
Debt/Equity Ratio | 0% |
How did ICO perform over the long term?
See historical performance and comparison